Goretti Duran

616 total citations
15 papers, 413 citations indexed

About

Goretti Duran is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Goretti Duran has authored 15 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 4 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Goretti Duran's work include Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (4 papers) and Genetic factors in colorectal cancer (3 papers). Goretti Duran is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Cancer Treatment and Pharmacology (4 papers) and Genetic factors in colorectal cancer (3 papers). Goretti Duran collaborates with scholars based in Spain, United Kingdom and Saudi Arabia. Goretti Duran's co-authors include María Jesús Lamas, Paula Sánchez‐Pintos, Álvaro Goyanes, María L. Couce, Abdul W. Basit, Miguel González Barcia, Simon Gaisford, Ãngel Carracedo, Farhan Taherali and Christine M. Madla and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and International Journal of Pharmaceutics.

In The Last Decade

Goretti Duran

13 papers receiving 408 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Goretti Duran Spain	9	217	152	107	74	38	15	413
Elie Akoury Canada	9	57 0.3×	27 0.2×	50 0.5×	88 1.2×	126 3.3×	17	331
Bramasta Nugraha Singapore	15	284 1.3×	23 0.2×	58 0.5×	224 3.0×	3 0.1×	21	541
Nathan Duarte Canada	4	208 1.0×	55 0.4×	20 0.2×	107 1.4×	4 0.1×	5	305
Zhixu He China	7	72 0.3×	35 0.2×	16 0.1×	53 0.7×	13 0.3×	16	249
Sangmin Lee South Korea	11	25 0.1×	60 0.4×	14 0.1×	75 1.0×	22 0.6×	28	399
Zejian Li China	13	42 0.2×	21 0.1×	34 0.3×	89 1.2×	7 0.2×	44	422
Monica Ramchandani United States	8	73 0.3×	8 0.1×	45 0.4×	47 0.6×	45 1.2×	13	432
Claudio Intini Italy	10	130 0.6×	50 0.3×	46 0.4×	48 0.6×	1 0.0×	23	396
Ni Kou China	9	78 0.4×	11 0.1×	27 0.3×	110 1.5×	4 0.1×	14	276
D.A. Kniss United States	6	128 0.6×	33 0.2×	17 0.2×	49 0.7×	22 0.6×	7	314

Countries citing papers authored by Goretti Duran

Since Specialization

Citations

This map shows the geographic impact of Goretti Duran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Goretti Duran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Goretti Duran more than expected).

Fields of papers citing papers by Goretti Duran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Goretti Duran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Goretti Duran. The network helps show where Goretti Duran may publish in the future.

Co-authorship network of co-authors of Goretti Duran

This figure shows the co-authorship network connecting the top 25 collaborators of Goretti Duran. A scholar is included among the top collaborators of Goretti Duran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Goretti Duran. Goretti Duran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Rodríguez‐Pombo, Lucía, Paula Sánchez‐Pintos, Patricija Januskaite, et al.. (2024). Paediatric clinical study of 3D printed personalised medicines for rare metabolic disorders. International Journal of Pharmaceutics. 657. 124140–124140. 38 indexed citations

Duran, Goretti, et al.. (2022). Medication adherence to obeticholic acid: a real-world experience using medication event monitoring systems.. PubMed. 46(4). 260–264.

Duran, Goretti, Raquel Cruz, Francisco Barros, et al.. (2021). Predictive value of ERCC2, ABCC2 and MMP2 of response and long-term survival in locally advanced head and neck cancer patients treated with chemoradiotherapy. Cancer Chemotherapy and Pharmacology. 88(5). 813–823. 7 indexed citations

Duran, Goretti, Raquel Cruz, Francisco Barros, et al.. (2020). Efficacy and toxicity of adjuvant chemotherapy on colorectal cancer patients: how much influence from the genetics?. Journal of Chemotherapy. 32(6). 310–322. 8 indexed citations

Goyanes, Álvaro, Christine M. Madla, Goretti Duran, et al.. (2019). Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients. International Journal of Pharmaceutics. 567. 118497–118497. 209 indexed citations

Maroñas, Olalla, Ana Latorre, Gema Barbeito Castiñeiras, et al.. (2019). Impact of CYP2C19 Genotype and Drug Interactions on Voriconazole Plasma Concentrations: A Spain Pharmacogenetic‐Pharmacokinetic Prospective Multicenter Study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 40(1). 17–25. 18 indexed citations

Duran, Goretti, Raquel Cruz, Francisco Barros, et al.. (2019). Association of GSTP1 and ERCC1 polymorphisms with toxicity in locally advanced head and neck cancer platinum‐based chemoradiotherapy treatment. Head & Neck. 41(8). 2704–2715. 10 indexed citations

Cueva, Juan, et al.. (2018). Real world of infusion related reactions in an oncology outpatient clinic.. Journal of Clinical Oncology. 36(15_suppl). e18872–e18872. 2 indexed citations

Duran, Goretti, et al.. (2015). Long Survival and Severe Toxicity Under 5-Fluorouracil–Based Therapy in a Patient With Colorectal Cancer Who Harbors a Germline Codon-Stop Mutation in TYMS. Mayo Clinic Proceedings. 90(9). 1298–1303. 7 indexed citations

10.

Lamas, María Jesús, et al.. (2012). The value of genetic polymorphisms to predict toxicity in metastatic colorectal patients with irinotecan-based regimens. Cancer Chemotherapy and Pharmacology. 69(6). 1591–1599. 21 indexed citations

11.

Lamas, María Jesús, Goretti Duran, Yolanda López‐Vidal, et al.. (2011). Use of a Comprehensive Panel of Biomarkers to Predict Response to a Fluorouracil–Oxaliplatin Regimen in Patients with Metastatic Colorectal Cancer. Pharmacogenomics. 12(3). 433–442. 33 indexed citations

12.

Lamas, María Jesús, Goretti Duran, Urbano Anido, et al.. (2010). X-Ray Cross-Complementing Group 1 and Thymidylate Synthase Polymorphisms Might Predict Response to Chemoradiotherapy in Rectal Cancer Patients. International Journal of Radiation Oncology*Biology*Physics. 82(1). 138–144. 27 indexed citations

13.

Lamas, María Jesús, Goretti Duran, Urbano Anido, et al.. (2010). Use of a comprehensive panel of biomarkers to predict response to a fluorouracil-oxaliplatin (mFOLFOX6) regimen in patients with metastatic colorectal cancer.. Journal of Clinical Oncology. 28(15_suppl). e13504–e13504.

14.

Duran, Goretti, María Jesús Lamas, Antonio Gómez‐Caamaño, et al.. (2010). Pharmacogenetic Analysis in Neoadjuvant Chemoradiation for Rectal Cancer: High Incidence of Somatic Mutations and their Relation with Response. Pharmacogenomics. 11(6). 747–761. 32 indexed citations

15.

Lamas, María Jesús, et al.. (2009). Analysis of pharmacogenetic biomarkers in rectal patients trated with chemoradiotherapy. Journal of Clinical Oncology. 27(15_suppl). e15051–e15051. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact